Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1
Authors:
- M.C. KrymMKM.C. Krym
- C.A. ThorntonCTC.A. Thornton
- 1 March 2007
- journal article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 17 (3) , 242-247
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- RNA-dominant diseasesHuman Molecular Genetics, 2006
- Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophyProceedings of the National Academy of Sciences, 2006
- Activity-Dependent Presynaptic Regulation of Quantal Size at the Mammalian Neuromuscular JunctionIn VivoJournal of Neuroscience, 2005
- Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutationEuropean Journal of Neuroscience, 2004
- Muscleblind proteins regulate alternative splicingThe EMBO Journal, 2004
- A Muscleblind Knockout Model for Myotonic DystrophyScience, 2003
- Localizing synaptic mRNAs at the neuromuscular junction: It takes more than transcriptionBioEssays, 2002
- Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophyThe EMBO Journal, 2000
- Myotonic dystrophy kinase is a component of neuromuscular junctionsHuman Molecular Genetics, 1993
- THE HISTOLOGY OF THE NEUROMUSCULAR JUNCTION IN DYSTROPHIA MYOTONICABrain, 1961